Combined Liver-Small Bowel Transplant in Children

Area of Science:

• Pediatric surgery
• Transplantation immunology
• Gastroenterology

Background:

• Combined liver-small bowel transplantation is a critical intervention for pediatric patients suffering from both intestinal failure and end-stage liver disease.
• Effective management necessitates precise patient selection based on factors like residual bowel length, enteral feeding tolerance, and the degree of liver fibrosis.

Purpose of the Study:

• To review the current state and future directions of combined liver-small bowel transplantation in pediatric patients.
• To highlight key factors influencing patient selection, surgical outcomes, and long-term management strategies.

Main Methods:

• Review of current literature on pediatric combined liver-small bowel transplantation.
• Analysis of patient selection criteria, surgical advancements, immunosuppression protocols, and perioperative care.
• Discussion of long-term follow-up strategies, including growth, neurodevelopmental, infection, and rejection surveillance.

Main Results:

• Significant improvements in survival rates have been achieved due to advances in surgical techniques, immunosuppression, and perioperative care.
• Multidisciplinary management, including growth and neurodevelopmental monitoring, is essential for optimizing long-term outcomes.
• Vigilant surveillance for infection and rejection is critical for patient well-being.

Conclusions:

• Combined liver-small bowel transplantation is a viable, lifesaving treatment for select pediatric patients with combined intestinal and liver failure.
• Future advancements in areas such as bioengineered grafts and perfusion techniques show promise for enhancing outcomes in this challenging patient group.